What Every MS Patient Should Know About Ocrevus and Its Use
With the recent approval of Ocrevus (ocrelizumab) for both primary progressive and relapsing multiple sclerosis (MS), interest in the medication is peaking.Ā To helpĀ readers of Multiple Sclerosis News TodayĀ better understandĀ this new medication and how it works, as well issues dealingĀ with access, use, and potential side effects, here is aĀ summary…